“…Two main single-centre studies have evaluated the validity of the Penn classification. The University of Pennsylvania group 13,18 introduced this classification system and categorized 221 AADA patients (mean age, 62 years, treated between 1993 and 2004) into four groups as follows: Aa (58%), Ab (18%), Ac (15%), Abc (9%). The Karolinska group 14 categorized 360 AAAD patients (mean age, 60 years, treated between 1990 and 2009) into Aa (61%), Ab (14%), Ac (18%) and Abc (7%).…”